F30 (Wenzhou Medical Univ.)

F30 (Wenzhou Medical Univ.): sourced facts only. name: "F30, an indazole derivative designed through computer-aided drug design targeting FGFR4, demonstrated anti-HCC activity as described in our previous studies." [PMID:38484925]; target: "F30, an indazole derivative designed through computer-aided drug design targeting FGFR4, demonstrated anti-HCC activity as described in our previous studies." [PMID:38484925]; developer: "School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, 325035, China." [PMID:38484925]; modality: "F30, an indazole derivative designed through computer-aided drug design targeting FGFR4, demonstrated anti-HCC activity as described in our previous studies." [PMID:38484925]; stage: "We report here that F30 could effectively induce ferroptosis in HCC cells." [PMID:38484925]